CD4 and dengue disease: Although recent clinical trial data showed that CD4+ T-cell responses induced by tetravalent live dengue vaccine largely focused on same epitopes as those detected in natural infection, but there were substantial serotype-specific epiotopes appeared in individuals received tetravalent live dengue vaccine (65).